4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-24-000480
Director sold 29,350 shares at an average $72.98 ($2,142,089)
- Director acquired 29,350 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
MUSSALLEM MICHAEL A · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-05 | Exercise or conversion : show line 1 in the form 10b5-1 | +29,350 | $36.75 | $1,078,613 | 33,835.82 | D |
| 2024-01-05 | Sale : show line 2 in the form 10b5-1 | −2,500 | $73.46 | $183,650 | 31,335.82 | D |
| 2024-01-05 | Sale : show line 3 in the form 10b5-1 | −26,850 | $72.94 | $1,958,439 | 4,485.82 | D |
| Open-market sales · 29,350 sh · avg $72.98 · $2,142,089 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2024-01-05 | Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −29,350 | $36.75 | 2024-05-10 | 29,350 | 117,400 | D |
Loading xslF345X05/doc4.xml…